Inder Singh is the founder & CEO of Kinsa. Kinsa's mission is to create a real-time map of human health to track—and curb—the spread of infectious illnesses. Inder has dedicated his life to improving child health and specifically, finding scalable ways to reduce the impact of infectious illness on children. Before starting Kinsa, Inder was the Executive Vice President of the Clinton Foundation's Health Access Initiative. In this position, Inder brokered the deals announced by former President Clinton that enabled more than 2 million people with HIV, malaria and TB to access life-saving medicines. These deals involved Inder negotiating $1.5 billion in cost savings from lower priced drugs and diagnostics on behalf of a consortium of 70 developing countries. Inder and his team were also instrumental in ensuring that more than 25 pediatric drug formulations were developed and brought to market in under 5 years, enabling more than 500,000 children to receive HIV treatment. Inder led or co-led a number of UNITAID-, DFID-, and Gates Foundation-funded programs including the largest pediatric and 2nd-line HIV programs in the world. Earlier in his career, Inder worked at three technology startups. He holds five academic degrees from the Harvard-MIT Division of Health Sciences & Technology, Harvard's Kennedy School, MIT Sloan, and the University of Michigan.